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BEHAVIORAL NEUROSCIENCE
in the neuropeptides substance P (Tac1) and dynorphin (Pdyn) 
and in dopamine D
1
 receptor (D
1
R; Drd1a) and M4 muscarinic 
acetylcholine receptor (Chmr4; Gerfen and Young, 1988; Gerfen 
et al., 1990; Le Moine et al., 1991; Bernard et al., 1992; Ince et al., 
1997). Striatopallidal neurons participate to the indirect pathway 
and project to the lateral globus pallidus (LGP). This indirect path-
way reaches the SNr/MGP by synaptic relay through the subtha-
lamic nucleus (STN). Striatopallidal neurons specifically express 
the neuropeptide enkephalin (Penk1) and dopamine D
2
 receptor 
(D
2
R; Drd2) and adenosine A
2A
 receptor (A
2A
R; Adora2a; Gerfen 
and Young, 1988; Gerfen et al., 1990; Schiffmann et al., 1991, 2007).
In the 90s, Albin et al. (1989) propose a model of the basal gan-
glia in which the direct and indirect pathways would have an oppo-
site but balancing role in the control of the motor behavior. In this 
model, the striatonigral direct pathway would promote the move-
ment whereas the striatopallidal indirect pathway would inhibit 
the motor behavior (Albin et al., 1989; Delong and Wichmann, 
2007). MSNs are also involved in reward and motivational processes 
(addiction) but their differential function in the establishment of 
such behavior are still poorly understood.
The two MSN populations are morphologically very similar and 
heterogeneously distributed in the striatum making difficult a spe-
cific identification and analysis. These characteristics preclude a sat-
isfactory demonstration of their differential functions in the motor 
and reward behavior for decades. The recent  emergence of new 
IntroductIon
The basal ganglia are composed of several interconnected nuclei 
involved in adaptive control of motor, cognitive, and motivational 
behavior. Dysfunctions of the basal ganglia system occur in several 
neuro-psychiatric diseases as Parkinson’s (PD) and Huntington’s 
diseases, addiction, attention deficit hyperactivity disorder 
(ADHD), schizophrenia, and Tourette’s syndrome (Delong, 1990; 
Comings, 2001; Saka and Graybiel, 2003; Chao and Nestler, 2004; 
Graybiel, 2005; Delong and Wichmann, 2007; Keshavan et al., 2008). 
The striatum, the main input structure of this system, is subdivided 
in a dorsal part mainly involved in motor control (Graybiel et al., 
1994; Hikosaka et al., 2000; Packard and Knowlton, 2002; Yin and 
Knowlton, 2006; Nicola, 2007) and the ventral striatum or nucleus 
accumbens (NAc) which is implicated in motivational and reward 
processes (Belin et al., 2009). In rodents, the striatum is composed 
of about 95% of GABAergic projection medium-sized spiny neu-
rons (MSNs) and 5% of interneurons, including three subtypes 
of GABAergic neurons and the large aspiny cholinergic neurons 
(Kawaguchi et al., 1995; Bolam et al., 2000; Tepper and Bolam, 
2004). MSNs can be subdivided in two neuronal sub-populations 
according to their projection sites and their expression in receptors 
and neuropeptides (Graybiel, 2000). Striatonigral neurons, giving 
rise to the direct pathway, project monosynaptically to the sub-
stantia nigra pars reticulata (SNr) and the medial globus pallidus 
(MGP), the output structures of basal ganglia. They are enriched 
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methodologies as BAC transgenesis, optogenetic, viral transgenesis 
allowing to target these neurons has given the opportunity to over-
ride this problem leading to a more specific investigation of stri-
atopallidal and striatonigral neuron functions in the basal ganglia 
circuit. Here, we review the most recent advances regarding the dif-
ferential role of striatopallidal and striatonigral neurons in the basal 
ganglia system. We will describe the innovative techniques used to 
investigate the gene expression profiles and the molecular pathways 
involved in the response to multiple stimuli (i.e., psychostimulants, 
6-OHDA-induced dopamine depletion l-DOPA) in the two MSN 
sub-populations. We will also discuss the important contribution of 
cell-specific ablation models and conditional knock-out models to 
unravel the functional roles of these striatopallidal and striatonigral 
neurons in the motor and motivational behavior.
BAc trAnsgenIc reporter mIce And evAluAtIon of 
moleculAr sIgnAlIng In strIAtopAllIdAl And 
strIAtonIgrAl neurons
The recent development of transgenic BAC reporter mouse lines 
in which the enhanced green fluorescent protein (EGFP) gene is 
selectively expressed in a large variety of neuronal sub-populations 
represents a powerful tool for identifying each neuronal subtype in 
different experimental paradigms. More particularly, BAC EGFP 
transgenic mice allowed to specifically identify and study the differ-
ential functional in vivo signaling of the two distinct MSN neuronal 
populations. In these transgenic mice, EGFP or dtTomato (a red 
fluorescent protein) are expressed under the control of Drd1a or 
Drd2 promoter in order to target the striatonigral (Drd1a–EGFP 
and Drd1a–dtTomato) and striatopallidal neurons (Drd2–EGFP), 
respectively (Gong et al., 2003; Shuen et al., 2008). The detailed 
study of the different mouse lines matched and confirmed previ-
ous in situ hybridization or immunohistochemical studies (Gerfen 
and Young, 1988; Le Moine et al., 1991; Schiffmann et al., 1991; 
Levesque et al., 2003) that led to the two-pathways model of basal 
ganglia. The Drd1a–EGFP and Drd1a–dtTomato mice, as well as A 
Chrm4-EGFP line, allowed the identification of striatonigral neu-
rons and their projection structures (MGD and SNr) whereas the 
Drd2–EGFP labeled striatopallidal neurons and their projection 
area (LGP) but also the cholinergic interneurons as well as neu-
rons in the substantia nigra pars compacta and ventral tegmental 
area corresponding to neurons expressing D
2
R as an autoreceptor 
(Gong et al., 2003; Bertran-Gonzalez et al., 2008; Shuen et al., 2008; 
Matamales et al., 2009). Thus, these mice are valid tools to specifi-
cally identify the two MSN populations and allowed to investigate 
and compare molecular pathways and molecular changes taking 
place in striatopallidal and striatonigral neurons in response to 
different stimuli (Bertran-Gonzalez et al., 2008, 2009; Borgkvist 
et al., 2008; Santini et al., 2009).
The extracellular signal regulated kinase (ERK) cascade is an 
important signaling pathway that underlies synaptic plasticity, cel-
lular excitability and learning. ERK is activated in the striatum by 
coordinated dopamine and glutamate receptor signaling, where it 
underlies corticostriatal synaptic plasticity and influences striatal 
cell excitability. ERK activation is necessary for action–outcome 
learning and performance of goal-directed actions (Shiflett and 
Balleine, 2010). The activation of the ERK pathway distinctly in 
the two MSN populations has been implicated in the long lasting 
effect of drugs of abuse (Valjent et al., 2006; Girault et al., 2007). 
 Bertran-Gonzalez et al. (2008) demonstrated by immunofluores-
cence on Drd2–EGFP and Drd1a–EGFP mice that the ERK pathway 
activation occurs specifically in striatonigral neurons after acute and 
even repeated cocaine administration. Moreover, this activation is 
concomitant to the phosphorylation of MSK1, an important player 
in the phosphorylation of CREB and histone H3 in the striatum 
in response to cocaine (Bertran-Gonzalez et al., 2008). This ERK 
pathway is also functional in striatopallidal neurons. The antip-
sychotic drug haloperidol known to antagonize D
2
R (Farde et al., 
1988) induced an activation of ERK, MSK1, and histone H3 exclu-
sively in striatopallidal neurons, showing the complete segregation 
between the striatopallidal and striatonigral signaling pathways 
within the striatum in response to diverse pharmacological stimuli 
(Bertran-Gonzalez et al., 2009). In contrast to striatonigral neurons, 
in striatopallidal neurons the H3 phosphorylation is occurring in an 
ERK–MSK1-independent manner (Bertran-Gonzalez et al., 2009). 
H3 phosphorylation involves the activation of the A
2A
R-Golf signal-
ing cascade leading to the DARPP-32 phosphorylation and the inhi-
bition of PP-1. Thus, the pathways involved in the phosphorylation 
of the histone H3, reflecting the chromatin remodeling, are clearly 
different in striatopallidal and striatonigral neurons. Santini et al. 
(2009) have demonstrated that the same molecular mechanism 
observed in response to drug of abuse in striatonigral neurons could 
be implicated in l-DOPA-induced dyskinesia. Single injection of 
l-DOPA in a 6-OHDA mouse model induced ERK activation in 
association with an increase of MSK1 and histone H3 phospho-
rylation. Moreover, chronic administration of l-DOPA produced a 
persistent increase of ERK, phospho-MSK1 and phospho-H3 only 
in dyskinetic but not in non-dyskinetic mice and this increase is 
restricted to striatonigral neurons (Santini et al., 2009). Therefore, 
this increase in phosphorylated H3 could be associated with gene 
expression changes in striatonigral neurons that might play a role 
in the development of l-DOPA-induced dyskinesia.
Dopamine and cAMP-regulated phosphoprotein of 32 kDa 
(DARPP-32) is a protein phosphatase inhibitor highly expressed 
in striatal MSNs (Walaas et al., 1983). DARPP-32 is a key regulator 
of protein phosphatase (PP-1) and protein kinase (PKA) signaling. 
DARPP-32 can be phosphorylated on different threonine residues 
that modify its activation state and induce opposite biochemi-
cal effects (inhibition of protein phosphatase or protein kinase; 
Fisone et al., 2007). Therefore, by acting on the phosphorylation 
state of multiple downstream targets, DARPP-32 is an important 
actor in striatal neurons; in control of their electrophysiological 
behavior and their implication in behavioral responses as reward, 
motor learning, and l-DOPA-induced dyskinesia (Valjent et al., 
2005; Fisone et al., 2007; Santini et al., 2009; Bateup et al., 2010). 
Considering this central role, the respective involvement of DARPP-
32 in striatopallidal and striatonigral neurons functions was exten-
sively studied. By using BAC transgenic mice expressing a tagged 
DARPP-32 specifically in striatopallidal or striatonigral neurons, 
Bateup et al. (2008) showed that the activation of D
1
R or D
2
R results 
in an opposite pattern of DARPP-32 phosphorylation. D
1
R activa-
tion leads to an increase of T34 phosphorylation and a decrease of 
T75 phosphorylation whereas D
2
R activation leads to the oppo-
site effect. Moreover, different subclasses of psychostimulant and 
antipsychotic drugs are able to induce cell-specific pattern of 
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D
2
-EGFP striatum induced about 50% loss of dendritic spines and 
glutamatergic synapses specifically in striatopallidal neurons as seen 
in the PD animal model (Day et al., 2006). This loss was dependent 
on Cav1.2, but not on Cav1.3 as in PD model (Day et al., 2006), on 
activation of calcineurin and up-regulation of one of its target Mef2 
which is highly expressed in striatopallidal neurons. This increase 
induces an up-regulation of two genes, Nur77 and Arc, known to 
be involved in down-regulation of glutamatergic synapses and inhi-
bition of synapse formation and dendritic spine differentiation 
(Steward and Worley, 2001; Shalizi et al., 2006; Shepherd et al., 
2006). These results therefore identified new mechanisms of activ-
ity-dependent synaptic scaling specifically in striatopallidal MSN.
specIfIc strIAtopAllIdAl And strIAtonIgrAl neurons 
trAnscrIptIonAl profIles
Genome-wide transcriptional analysis has also recently emerged as 
a powerful tool to investigate the differential gene expression and 
gene function of defined cell types.
Recent studies have identified new molecular targets specific 
to either striatopallidal or striatonigral neurons (Lobo et al., 2006; 
Heiman et al., 2008). The molecular profiling is an important key 
to unravel the molecular differences between the two MSN popu-
lations in order to better understand their differential functions 
in the basal ganglia system. By FACS-array profiling of D
1
-EGFP 
and D
2
-EGFP neurons, Lobo et al. (2006) identified a subset of 
new striatopallidal and striatonigral neuron-enriched genes. They 
have demonstrated the important role of Ebf1 selectively enriched 
in striatonigral neurons as regulator of the striatonigral neuron 
differentiation in the striatal matrix compartment (Lobo et al., 
2008). Moreover, they identified a new striatal-specific constitu-
tive G protein-coupled receptor (GPCR), GPR6, which is selec-
tively expressed in striatopallidal neurons. Analysis of GPR6 KO 
mice demonstrated that this sphingosine-1-phosphate receptor is 
a critical factor in the striatal production of cAMP. GPR6 KO mice 
exhibited deficits in instrumental conditioning by which animal 
learn to obtain a reward by performing a simple task, whereas 
the locomotor behavior and the motor learning in a rotarod task 
were normal (Lobo et al., 2007). Therefore, GPR6 seems to be an 
important and new actor in molecular mechanisms underlying 
instrumental conditioning and points out the role of striatopallidal 
neurons in mediating this behavior.
Since gene profiling is therefore a powerful methodology to 
investigate the differences at the molecular level in striatopallidal 
and striatonigral neurons and to identify key genes or molecular 
pathways involved in the basal ganglia physiology, it should also 
provide new mechanistic data in models of pathological conditions 
of the basal ganglia circuit as in addiction or PD. Heiman et al. 
(2008) developed a TRAP (translating ribosome affinity purifica-
tion) approach consisting in the generation of BAC transgenic mice 
expressing the EGFP-tagged ribosomal protein L10a specifically in 
striatopallidal and striatonigral neurons via the Drd2 and Drd1a 
gene promoters, respectively. After an affinity purification of the 
EGFP-L10a protein with an antibody against EGFP, the enriched 
ribosome and the associated mRNA were used to determine the 
translational profiles of both MSN populations (Heiman et al., 
2008). This led to the confirmation of the Lobo’s study and the 
identification of many new genes enriched in either striatopalli-
DARPP-32 phosphorylation. Whereas cocaine induces specific T34 
 phosphorylation in striatonigral neurons, haloperidol treatment 
induces the same phosphorylation exclusively in striatopallidal 
neurons (Bateup et al., 2008). Moreover, Stipanovich et al. (2008) 
have shown using Drd1a–EGFP mice that psychostimulant injec-
tion lead to the nuclear accumulation of phospho-T34-DARPP-32 
in striatonigral neurons. They demonstrated that D
1
R activation 
leads to the phosphorylation of DARPP-32 on serine 97 that is 
responsible for the nuclear export and accumulation of DARPP-
32. This accumulation is also required for the phosphorylation of 
histone H3 and then is essential for regulation of gene expression. 
The knock-in mouse model bearing a point mutation of the serine 
97 in alanine (S97A) showed that S97 mutation, and hence disrup-
tion of DARPP-32 nuclear accumulation, produced alteration in the 
long lasting effect of drug of abuse, and decreased motivation for 
food reward (Stipanovich et al., 2008). Meurers et al. (2009) have 
also recently shown in a striatopallidal and striatonigral neurons 
profile analysis that DARPP-32 pathway seems to be the target of 
adaptive modification in the two MSN populations in response to 
dopamine depletion and l-DOPA treatment.
Besides differences in signaling pathways, the study on Drd1a- 
and Drd2-EGFP mouse lines also allowed to firmly demonstrate in 
striatopallidal and striatonigral neurons specific synaptic adapta-
tions and plasticity such as structural changes associated to different 
conditions like induction of addictive behavior or motor deficits 
in PD. It is first worth to note that these mouse lines allowed to 
identify subtle morphological differences between D
1
- and D
2
-GFP 
neurons with higher total dendritic length and higher number of 
primary dendrites in striatonigral than in striatopallidal neurons 
(Gertler et al., 2008).
Lee et al. (2006) have demonstrated an increase in spine den-
sity both in striatonigral and striatopallidal neurons after chronic 
methylphenidate and cocaine treatments. However, this increase 
persisted in striatonigral neurons after 1 month withdrawal whereas 
it rapidly disappeared in striatopallidal neurons similarly to the 
increase in ∆FosB expression (Lee et al., 2006), suggesting that the 
increase of dopaminergic tonus is responsible for the increase of 
spine density in both MSN sub-populations but with highly dif-
ferent long-term consequences.
On the other hand, Day et al. (2006) demonstrated that 
6-OHDA-induced dopamine depletion provoked a selective loss 
of glutamatergic synapses in striatopallidal neurons, without any 
spine density modifications in striatonigral neurons, by a mecha-
nism resulting from the dysregulation of the l-type Ca2+ channel 
Cav1.3 in the spine. Such dendritic spine density modification 
should alter striatopallidal MSN activity and lead to a failure in 
the correct control of the pallido-subthalamic circuit that could 
explain motor dysfunction observed in PD. This decrease could be 
viewed as a homeostatic plasticity to adapt to the decrease in D
2
R 
activation on striatopallidal neurons. This homeostatic hypothesis 
is also validated by the coincidence in these MSNs of an increased 
intrinsic excitability and a large decrease in their excitatory synap-
tic inputs resulting from the loss in dendritic spines in dopamine 
depletion condition (Azdad et al., 2009a).
Allowing to better understand the homeostatic control of spine 
density in striatopallidal neurons, Tian et al. (2010) demonstrated 
that sustained depolarization of co-culture of cerebral cortex and 
Ena et al. Differential functions of striatal sub-populations
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result by using optogenetic control of the two MSN populations. 
In this approach, adenovirus-associated viruses (AAV1) containing 
the channel rhodopsin 2 (Chr2) fused to enhanced yellow fluores-
cent protein (YFP) were injected into the dorsal striatum of BAC 
transgenic mice expressing the Cre recombinase in striatopallidal 
or striatonigral neurons (Kravitz et al., 2010; D
2
-Cre and D
1
-Cre 
respectively Gong et al., 2007). In D
2
-Chr2 mice, illumination of 
the dorsal striatum induced an activation of striatopallidal neu-
rons leading to a decrease in locomotor initiation and an increase 
of freezing. In contrast, the activation of striatonigral neurons in 
D
1
-Chr2 mice led to the opposite phenotype, with an increase in 
locomotor initiation and decrease in freezing (Kravitz et al., 2010). 
Moreover, bilateral illumination of dopamine-depleted striatum 
in D
1
-Chr2 mice completely restored a normal motor behavior by 
eliminating bradykinesia, increasing the locomotor initiation, and 
decreasing freezing; firmly demonstrating the role of the activation 
of the direct pathway for improvement of motor deficits in PD 
(Kravitz et al., 2010).
The respective roles of striatopallidal and striatonigral neurons 
in the control of motivational and reward behavior are so far also 
poorly understood. However, thanks to the development of condi-
tional tools, several recent studies have successfully addressed this 
issue. Durieux et al. (2009) have demonstrated that the conditional 
and specific ablation of striatopallidal neurons in the NAc induced 
an increase in drug reinforcement as demonstrated by an increased 
amphetamine conditioned place preference (CPP), strongly sug-
gesting the role of striatopallidal neurons in inhibition of drug 
reinforcement.
Ferguson et al. (2010) have more recently developed a new sys-
tem in rat based on the use of viral vector with Enkephalin (Penk) 
or Dynorphyn (Pdyn) gene promoters allowing the expression of 
the new engineered GPCR hMD4 specifically in striatopallidal or 
striatonigral neurons, respectively. The stimulation of hMD4, a G
i/o
 
coupled GPCR, by a specific ligand CNO induces the activation 
of Kir3 resulting in a membrane hyperpolarization and, hence, 
a transient neuronal silencing. In this model, administration of 
CNO in Penk-hMD4 or Pdyn-hMD4 rats resulted in an increase 
and a decrease of amphetamine-induced sensitization, respectively 
(Ferguson et al., 2010). Lobo et al. (2010) have also addressed 
this question by using optogenetic control of striatopallidal and 
striatonigral neurons but also by generating conditional loss of 
TrkB in striatopallidal and striatonigral neurons using D
2
-Cre ad 
D
1
-Cre transgenic mice. They demonstrated that the activation of 
the indirect pathway in a CPP paradigm led to a decrease of the 
rewarding effect of cocaine whereas the activation of the direct 
pathway resulted in the opposite phenotype (Lobo et al., 2010). 
Finally, Hikida et al. (2010) have also targeted striatonigral and 
striatopallidal neurons by using viral vectors and Tac1 or Penk gene 
promoters allowing the expression of tTA in transgenic mice con-
taining the TRE–GFP–Tetanus Toxin transgene leading to the inhi-
bition of neurotransmission in targeted neurons. Blockade of the 
direct pathway showed a decrease in cocaine-induced CPP whereas, 
in contrast to the studies reported above, no difference in CCP 
was found when the indirect pathway was inhibited (Hikida et al., 
2010). These differences could be explained by the lower proportion 
(60–70%) of neurons targeted by the two approaches. Altogether, 
by using different approaches, all based on conditional expression 
dal or striatonigral neurons. This subset of genes has been also 
 validated in adult mice by our group using FACS-array profiling of 
EGFP striatopallidal neurons targeted with the Adora2a-Cre mice 
(Durieux et al., 2009) and striatonigral neurons simultaneously 
identified by retrograde labeling (Ena et al., unpublished data).
Heiman et al. (2008) approach was also used to track for differ-
ential modifications in gene expression profiles in response to phar-
macological perturbations. For instance, besides the identification 
of various genes whose expression has been previously reported to 
be affected, an up-regulation of the GABA signaling pathway was 
specifically demonstrated in striatonigral neurons upon chronic 
cocaine treatment (Heiman et al., 2008). Accordingly, electrophysi-
ological recordings showed specific increase in mIPSC in stria-
tonigral neurons (Heiman et al., 2008). Increased expression in 
GABA
A
 receptor in striatonigral neurons could be part of molecular 
adaptive changes to the increased excitatory drive on these neurons 
and, hence, could be associated with the modification in sensitivity 
observed in chronic cocaine addicts. In contrast to this hyperdopa-
minergic situation upon psychostimulant treatment, Meurers et al. 
(2009) have recently shown that the expression of multiple com-
ponents and targets of the cAMP/DARPP-32 signaling pathway are 
affected in mouse model of PD (6-OHDA mouse model) and after 
chronic l-DOPA treatment leading to l-DOPA-induced dyskinesia. 
By using an experimental approach based on a microarray analysis 
of laser-dissected striatopallidal and striatonigral neurons, these 
authors identified several gene categories (ion channels, receptors, 
signaling molecules) affected by the dopamine depletion. These 
genes were either altered exclusively in one population or in an 
opposite manner in the striatopallidal and striatonigral neurons. 
Moreover, Meurers and colleagues highlighted a cell-specific regula-
tion of gene expression in response to chronic l-DOPA treatment, 
which could give new insight about the mechanism involved in the 
development of this condition.
evAluAtIon of the dIfferentIAl roles of 
strIAtopAllIdAl And strIAtonIgrAl neurons In 
motor And rewArd BehAvIors By cell-type specIfIc 
ActIvAtIon or ABlAtIon
According to the classical model of the basal ganglia, the two neu-
ronal MSN populations exert opposite control on motor behavior. 
Activation of the “direct” pathway would lead to the facilitation of 
movements whereas the activation of the “indirect” pathway should 
inhibit the movement. However, the hypothesis was not experimen-
tally validated because of the lack of tools allowing the specific study 
of these two morphological and intermixed neuronal populations 
in vivo. In the last 2 years, several groups have developed such 
tools allowing the analysis of functional differences between striato-
pallidal and striatonigral neurons in motor and reward behaviors. 
Durieux et al. (2009) have generated a conditional striatopallidal 
neuron ablation model based on an Adora2a-Cre BAC transgenic 
mouse. The specific ablation was obtained by stereotaxic injection 
of diphtheria toxin (DT) in the Adora2a-Cre mouse crossed with an 
inducible diphtheria toxin receptor (iDTR) mouse line (Buch et al., 
2005). The bilateral injection of DT in the striatum induces a spon-
taneous hyperlocomotion compared to the control mice, defini-
tively demonstrating the inhibitory role of striatopallidal neurons 
in the motor activity. Kravitz et al. (2010) recently confirmed this 
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approaches. NMDA receptors are involved in the corticostriatal 
excitatory glutamatergic transmission on MSNs and play a cen-
tral role in synaptic plasticity at these synapses (Calabresi et al., 
1992). By using Drd1a- and Drd2-EGFP, Shen et al. (2008b) recently 
demonstrated the role of NMDA receptor in inducing long-term 
potentiation (LTP) either in striatopallidal or striatonigral neurons 
and its uselessness in the induction of long-term depression (LTD) 
in both populations. This could fit with several pharmacological 
studies showing the implication of striatal NMDA receptors in 
instrumental learning (Yin et al., 2005). By using a striatal-specific 
Cre mice (RGS9-Cre) and NMDAR1 (NR1) floxed mice, Dang et al. 
(2006) have demonstrated that deletion of NR1 subunit in the entire 
striatum led to a deficit in motor learning in a rotarod task associated 
with abolition of LTP in the dorsal striatum and LTD in the NAc. 
Agatsuma et al. (2010), showed more recently the involvement of 
striatal NR1 subunit in cocaine cue reactivity in a CPP paradigm. 
However, this model did not allow studying specific involvement of 
this receptor in the two MSN populations. To more specifically focus 
on striatonigral neurons, Heusner and Palmiter (2005) developed 
a knock-in model targeting expression of a NR1 subunit mutant 
driven by the D
1
 receptor promoter (Heusner and Palmiter, 2005) 
and, more recently, Beutler et al. (2011) crossed knock-in Drd1a-
Cre mice with NR1 floxed mice. They demonstrated by these two 
independent approaches that altering NMDA signaling by either 
NR1 subunit deletion or NR1 mutant expression did not affect basal 
locomotor activity or acute locomotor response to psychostimulant 
(Heusner and Palmiter, 2005) but abolished the establishment of 
cocaine and amphetamine sensitization. Moreover, mice deleted in 
active NMDA receptors in striatonigral neurons are less sensitive 
to the rewarding effect of cocaine and amphetamine tested in a 
CPP paradigm compared to the wild-type littermates (Heusner and 
Palmiter, 2005; Beutler et al., 2011). Moreover, re-expression of NR1 
only in striatonigral neurons by injection of AAV vector in the NAc 
of Drd1a-Cre mice restored amphetamine sensitization, therefore 
showing that the expression of NR1 in D
1
-expressing cells is suf-
ficient to the development of AMPH sensitization (Beutler et al., 
2011). In contrast, they also demonstrated that balanced loss of 
NMDA receptors in both MSN subtypes by using GPR88-Cre mice 
is permissive for the development of the sensitization. Therefore, 
removing the NMDA receptors and so compromising the gluta-
matergic activation in striatonigral neurons leads to an imbalance 
activity between the two MSN classes that probably promotes the 
inhibitory role of striatopallidal neurons on amphetamine sensi-
tization. This indicates that an antagonistic balanced activity of 
striatopallidal and striatonigral neurons is also at works during the 
establishment of drug sensitization.
Besides ionotropic glutamate receptors, MSNs also highly 
express members of the group 1 metabotropic glutamate receptors 
(mGluR; Tallaksen-Greene et al., 1998). MSNs co-express mGluR1 
and mGluR5 known to modulate their synaptic activity. mGluR1 
and/or mGluR5 are involved in the potentiation of NMDA current, 
the suppression of GABAergic and glutamatergic transmissions via 
the activation of presynaptic CB1 receptors as well as in corticos-
triatal LTP and LTD (for review Bonsi et al., 2008). These forms 
of plasticity in striatal MSNs are proposed to be associated with 
motor learning but also associative learning and memory processes 
that might contribute to relapse like-behavior. The contribution 
in MSN populations, these studies demonstrated that similar to 
their functions in motor control, striatopallidal, and striatonigral 
neurons display antagonistic roles in the control of reward behavior.
Optogenetic tools have also recently been used to investigate the 
involvement of NAc cholinergic interneurons in drug reinforce-
ment. By conditional expression of ChR2 or the chloride pump 
halorhodopsin (eNpHR3.0) in choline acetyltransferase (ChAT)-
positive neurons, Witten and colleagues have demonstrated that the 
activation of cholinergic neurons by stimulation of ChR2 induced 
the decrease of MSN firing whereas their inhibition by stimulation 
of eNPHR3.0 induced an increase in MSNs firing in NAc (Witten 
et al., 2010). The inhibition of ChAT interneurons during cocaine 
exposure in the conditioning phase of a CPP paradigm induced a 
significant decrease in cocaine-induced CPP, demonstrating that 
striatal cholinergic interneurons control NAc MSN activity and 
consequently regulate cocaine-reward properties (Witten et al., 
2010).
evAluAtIon of the dIfferentIAl roles of 
strIAtopAllIdAl And strIAtonIgrAl neurons In 
motor And rewArd BehAvIors By cell-type specIfIc 
gene overexpressIon or InActIvAtIon
Thus, the recent development of these powerful techniques allowed 
to more precisely study the functional roles of striatopallidal and 
striatonigral neurons. Furthermore, the elucidation of these func-
tional differences was also more and more addressed by using mice 
with cell-specific knock-out/knock-down of selected genes (i.e., ion 
channel, receptor) based on BAC-driven Cre recombinase expres-
sion or small hairpin RNA (ShRNA).
The first developed conditional striatonigral and striatopallidal 
models were the NSE-tTa 11A and 11B (tetracycline transactiva-
tor) mice which, when crossed with a transgenic line expressing a 
gene of interest driven by Tet-Op (tetracycline promoter), lead to 
the induction of this gene expression in the absence of doxycycline 
(Kelz et al., 1999; Werme et al., 2002). These models were particu-
larly interesting because the gene expression can be induced at 
adulthood and then avoids developmental effect or gene compen-
sation. Roles of ∆FosB, a transcription factor involved in response 
to drugs of abuse, have been studied in striatopallidal and stria-
tonigral neurons using this strategy. Overexpression of ∆FosB in 
striatonigral neurons increased the reward and locomotor response 
to cocaine and morphine (Kelz et al., 1999; Zachariou et al., 2006) 
whereas overexpression in striatopallidal neurons did not affect 
the morphine reward properties (Zachariou et al., 2006), strongly 
supporting an instrumental role of ∆FosB in striatonigral neurons 
in reward properties of drugs.
Besides this first conditional model in the basal ganglia system, 
several groups also developed and used knock-in and BAC trans-
genic mice to express, under specific striatopallidal or striatonigral 
neuron promoters, either a protein of interest (Drago et al., 1998; 
Sano et al., 2003; Gantois et al., 2007), a mutant protein (Heusner 
and Palmiter, 2005), a shRNA (Novak et al., 2010) or the Cre recom-
binase used with conditional knock-out floxed mice (Heusner and 
Palmiter, 2005; Lemberger et al., 2007; Durieux et al., 2009).
The study of NMDA receptor roles in motor and reward func-
tions in the striatum and more specifically in striatonigral neurons 
is a good example to demonstrate the usefulness of these different 
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addition and in the same line, Bateup et al. (2010) demonstrated 
that DARPP-32 deletion in striatopallidal neurons abolished the 
haloperidol-induced catalepsy.
BDNF-Trkb signaling has been implicated in the reward-
ing response to psychostimulants (Grimm et al., 2003; Graham 
et al., 2007, 2009; Schoenbaum et al., 2007) but the role of the 
striatopallidal and striatonigral neurons in this mechanism 
remains unclear. TrkB is expressed by both MSN subtypes but 
Trkb is significantly enriched in striatopallidal neurons (Lobo 
et al., 2010). Alteration BDNF-Trkb signaling induced molecular 
changes as showed by the surprising increase in c-fos expression 
in striatopallidal neurons and decrease in striatonigral neurons 
upon acute cocaine treatment while previous studies have dem-
onstrated the selective increase of c-fos expression in striatonigral 
neurons (Bertran-Gonzalez et al., 2008). This alteration in c-fos 
expression is associated with a modification in MSN excitability. 
Striatopallidal neurons displayed a dramatic increase in neuronal 
firing in basal condition whereas striatonigral neurons displayed 
this increase only after cocaine treatment, probably due to K+ 
channel down-regulation. The increase in striatopallidal activity 
leads to the desensitization of the rewarding effect of cocaine 
whereas increase excitability of striatonigral neurons promotes 
the effect of cocaine (Lobo et al., 2010). Cell-specific deletion of 
Trkb confirmed the antagonistic role of striatopallidal and stria-
tonigral neurons in the locomotor response to cocaine treatment, 
which is consistent with current models of basal ganglia circuit 
(Lobo et al., 2010).
As indicated above, Lobo et al. (2007) studied the new striato-
pallidal neuron-specific gene Gpr6 by using full knock-out mice 
highlighting its involvement in the control of the cAMP signaling 
cascade in these neurons and its role in instrumental learning. 
Involvement of adenosine A
2A
 receptor, a well-known striatopalli-
dal neuron-specific gene (Schiffmann and Vanderhaeghen, 1993; 
Schiffmann et al., 2007), has been extensively studied by using 
pharmacological tools and knock-out mice leading to apparent 
discrepant results. Contrary to the antagonist A
2A
-D
2
 interac-
tion model in the striatum (Ferre et al., 1997), based on various 
data including electrophysiological studies showing antagonistic 
A
2A
-D
2 
control of D
2
-GFP MSN membrane potential oscillations 
through A
2A
-D
2
 receptors heteromerization (Azdad et al., 2009b) 
and pharmacological studies (Filip et al., 2006), global genetic 
deletion (Chen et al., 2000, 2003; Soria et al., 2006) or more spe-
cific deletion in the forebrain (using CamKIIα-Cre mouse line 
and floxed A
2A
 receptor mice; Bastia et al., 2005) led to an attenu-
ation rather than a increase of the locomotor effect induced by 
psychostimulants. Reconciling these different results, deletion 
of A
2A
 receptor specifically at the post-synaptic level in striatal 
neurons by using Dlx5-6-Cre mice showed that, in contrast to 
forebrain deletion, acute administration of cocaine resulted in an 
enhanced cocaine-induced locomotor activity (Shen et al., 2008a), 
that could be explained by the antagonistic interaction between 
A
2A
R and D
2
R in striatopallidal neurons. These results showing 
opposite effects of pre- and post-synaptic A
2A
R nicely illustrate the 
importance of having adequate tools to inactivate genes in specific 
neuronal populations to decipher their functions. In addition, 
using devaluation omission behavioral assay for habit formation, 
Yu et al. (2009) demonstrated that A
2A
R deletion in striatopallidal 
of mGluR5 in these processes, either in striatonigral neurons or 
striatopallidal neurons, was investigated through the development 
of a mGluR5 knock-down mice (mGluR5KD-D1) expressing a small 
hairpin RNA targeting the mGluR5 under the control of D
1
 receptor 
promoter (Novak et al., 2010). By using a model of cue-induced 
reinstatement, Novak et al. (2010) showed that mGluR5 in stria-
tonigral MSNs play a role in the reinstatement of cocaine behavior 
and is therefore required for specific incentive learning processes.
In addition to the central and interrelated roles of glutamater-
gic and dopaminergic transmissions, muscarinic acetylcholine 
receptors (Chmr) also tightly regulate the basal ganglia network. 
Disturbances in cholinergic transmission in this system have 
been suggested in pathologies as Parkinson’s disease, depression, 
schizophrenia, and drug addiction (Felder et al., 2001; Langmead 
et al., 2008) and Chmr4 knock-out mice revealed their role in 
the modulation of the dopaminergic system activity through pre- 
and/or post-synaptic mechanisms (Gomeza et al., 1999; Tzavara 
et al., 2004).
Interestingly, Chmr4 are specifically co-expressed with dopamine 
D
1
 receptor in striatonigral neurons (Bernard et al., 1992; Ince et al., 
1997). The physiological relevance of this specific cellular expres-
sion was recently analyzed by using the Cre/LoxP system to generate 
mice lacking Chmr4 specifically in D
1
 receptor-expressing striatoni-
gral neurons (D
1
-M4-KO; Jeon et al., 2010). Phenotypical analyses 
of these D
1
-M4-KO mice revealed increase in their response to 
psychostimulants with increased hyperlocomotion to acute cocaine 
and amphetamine treatment and increased amphetamine-induced 
behavioral sensitization. This was accompanied by alterations in 
dopaminergic transmission, which could contribute to the hyper-
sensitivity phenotype, both at the pre- and post-synaptic levels with 
an increased dopamine efflux in NAc and a lack of control of the 
D
1
-mediated signaling cascade in striatonigral neurons (Jeon et al., 
2010), showing therefore the role of striatonigral MSN-expressed 
Chmr4 in the behavioral response to psychostimulants.
In contrast to striatonigral neurons, only few studies have 
been designed to examine and understand the roles of specific 
molecules in striatopallidal neurons in behavior. Nevertheless, 
the involvement of DARPP-32 and BNDF-Trkb signaling in both 
striatopallidal and striatonigral neurons has been investigated by 
conditional cell-specific deletion using Drd2-Cre and Drd1a-Cre 
mouse lines (Bateup et al., 2010; Lobo et al., 2010). Bateup and 
colleagues first demonstrated that DARPP-32 is essential for the 
induction for corticostriatal LTP both in striatopallidal and stria-
tonigral neurons. Further, they showed that conditional deletion of 
DARPP-32 induces opposite behavioral alterations. Thus, the loss of 
DARPP-32 in striatopallidal neurons leads to an increased activity 
whereas this loss in striatonigral neurons results in decreased activ-
ity in basal and cocaine-induced locomotor activity. Cell-specific 
alterations of this signaling cascade highlighted that striatopallidal 
and striatonigral neurons exert an antagonistic control in mediat-
ing locomotor activity and behavioral effect of psychostimulants; 
striatonigral and striatopallidal neurons facilitating and inhibiting 
locomotion and rewarding effect of psychostimulants, respectively. 
Interestingly, only the loss of DARPP-32 in striatonigral neurons 
fully abolished l-DOPA-induced dyskinesia whilst its deletion in 
striatopallidal was without effect suggesting the important role 
of striatonigral DARPP-32 in the l-DOPA-induced dyskinesia. In 
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MSNs provided a huge number of new genes and molecular path-
ways that are specifically present in striatopallidal and striatonigral 
neurons. The functional relevance of these genes and pathways 
represent an important challenge that will be analyzed in the future. 
Finally, the development of cell-specific models using Cre lines and 
conditional floxed mice is profoundly changing the way we ana-
lyze basal ganglia functions and allows to much better investigate 
striatopallidal and striatonigral neuron properties and to dissect 
molecular mechanisms underlying their differential functions in 
the basal ganglia circuit.
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neurons led to a selective deficit in instrumental learning and hence 
revealed the importance of A
2A
R-mediated signaling cascade in 
striatopallidal neurons for habit formation.
conclusIon
Data summarized in this review extraordinarily extend our under-
standing of signaling pathways and mechanisms that are selectively 
activated in striatopallidal and striatonigral neurons in response 
to different stimuli, demonstrating the differential implication of 
these neuron sub-populations in the control of motor and drug-
induced behaviors (see Tables 1 and 2). This rapid extension was 
render possible by the critical development of new technologies in 
the last decade allowing to specifically identify and study these two 
key neuronal populations in the striatum.
First, specific identification of striatopallidal and striatonigral 
neurons has given the opportunity to investigate more precisely 
molecular pathways involved in different conditions, i.e., in psycho-
stimulant responses. Furthermore, genome wide analysis of striatal 
Table 1 | Behavioral phenotype in striatopallidal neuron-specific transgenic mouse models.
Specific neuronal inhibition or ablation model Specific neuronal activation model (optogenetic tools)
Increased basal locomotor activity (Durieux et al., 2009) Decreased basal locomotor activity and increased freezing (Kravitz et al., 2010)
Increased rewarding effect of amphetamine (Durieux et al., 2009) Decreased rewarding effect of cocaine (Lobo et al., 2010)
Increased amphetamine sensitization (Ferguson et al 2010)
SpeciFic geNe TargeTiNg
Increased basal locomotor activity in DARPP-32 conditional  Habit formation alteration in striatopallidal neuron-A2AR knock-out (Yu et al., 2009) 
knock-out mice (Bateup et al., 2010)
Increased acute cocaine-induced hyperlocomotion in DARPP-32  Instrumental conditioning affected by GPR6 deletion (Lobo et al., 2007) 
conditional knock-out mice (Bateup et al., 2010)
Decreased rewarding effect of cocaine in TrkB conditional  Disruption of haloperidol-induced catalepsy (Bateup et al., 2010) 
knock-out mice (Lobo et al., 2010)
Table 2 | Behavioral phenotype in striatonigral neuron-specific transgenic mouse models.
Specific neuronal inhibition model (optogenetic tools) Specific neuronal activation model (optogenetic tools)
Decreased amphetamine sensitization (Ferguson et al., 2010) Increased basal locomotor activity and
Increased rewarding effect of cocaine (Lobo et al., 2010) decreased freezing (Kravitz et al., 2010)
SpeciFic geNe TargeTiNg
Decreased basal locomotor activity, acute cocaine-induced hyperlocomotion  Alteration of cue-induced reinstatement in striatonigral  
and l-DOPA-induced dyskinesia in DARPP-32 conditional  neuron mGluR5 knock-down mice (Novak et al., 2010)
knock-out mice (Bateup et al., 2010)
Increased locomotor response and rewarding effect of cocaine and Increased cocaine and amphetamine acute 
morphine by ∆FosB overexpression (Zachariou et al.,2006) hyperlocomotion and behavioral sensitization 
 in D1-M4-KO (Jeon et al., 2010)
Increased rewarding effect of cocaine in TrkB conditional  Abolished sensitization and decreased rewarding effect of  
knock-out mice (Lobo et al.,2010) psychostimulant in striatonigral neuron NR1  
 subunit-lacking mice (Beutler et al., 2011)
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